BrightView Executive and Leadership Team

Chad Smith, the Chief Executive Officer at BrightView, directs the overarching strategic vision for outpatient addiction treatment programs. Smith architects the expansion of evidence-based care models, ensuring that medical treatment, psychological therapy, and social services remain integrated for every patient. By aligning clinical outcomes with organizational growth, the Chief Executive Officer maintains high standards of patient-focused care across all regional facilities. Smith monitors market trends to refine the delivery of addiction recovery services, fostering a culture of compassion and commitment. Through constant collaboration with the board and senior leadership, the Chief Executive Officer drives the mission to improve lives without requiring patients to uproot existing personal commitments. This leadership role involves scaling operations to meet rising demand while upholding the rigorous clinical protocols that define the company's reputation in the healthcare sector.

Felicia Lekan-Salami, the Founder & Chief Executive Officer at BrightView, establishes the foundational philosophy of patient-centered recovery. Lekan-Salami drives the development of innovative outpatient models that combine medical intervention with essential social services. As the Founder & Chief Executive Officer, this leader shapes the long-term trajectory of the organization, ensuring that every clinical decision reflects a deep commitment to evidence-based practices. By overseeing the integration of psychological therapy into standard treatment pathways, Lekan-Salami guarantees that patients receive comprehensive support during the recovery process. This executive role involves championing the company's mission to reach as many individuals as possible, effectively balancing rapid organizational scaling with the maintenance of high-quality care standards. Through strategic partnerships and continuous refinement of service delivery, Lekan-Salami secures the company's position as a leader in the addiction treatment landscape.

Bradley Barker, the Chief Financial Officer at BrightView, manages the fiscal health and resource allocation necessary to sustain high-quality addiction treatment programs. Barker architects financial strategies that support the expansion of outpatient facilities, ensuring that capital investments align with the company's mission of accessible care. The Chief Financial Officer oversees budgeting, revenue cycle management, and long-term financial planning to maintain operational stability. By analyzing performance metrics across various regions, Barker optimizes resource distribution to maximize patient impact. This leadership role requires close coordination with the executive team to ensure that financial growth supports the delivery of medical and psychological services. Through rigorous fiscal oversight, the Chief Financial Officer enables the organization to scale effectively while maintaining the integrity of the patient-focused model. Bradley Barker secures the financial foundation required to sustain long-term recovery initiatives.

Dylan Jackson, the Chief Operating Officer at BrightView, directs the day-to-day operations of outpatient addiction treatment centers to ensure consistent service delivery. Jackson architects efficient workflows that integrate medical treatment with psychological therapy, allowing for a seamless patient experience. The Chief Operating Officer oversees the management of clinical staff and facility resources, ensuring that every location adheres to the company's evidence-based standards. By monitoring operational performance across diverse markets, Jackson identifies opportunities for process improvement and service expansion. This leadership role involves balancing the logistical demands of a growing healthcare network with the need for compassionate, patient-focused care. Through the implementation of scalable operational models, the Chief Operating Officer supports the company's mission to reach more individuals in need. Dylan Jackson drives the operational excellence required to maintain high recovery success rates.

Colin Weidmann, the Chief of Staff at BrightView, coordinates cross-functional initiatives to ensure seamless alignment between clinical operations and administrative goals. Weidmann facilitates communication across the executive leadership team, driving the execution of strategic projects that enhance patient care delivery. As the Chief of Staff, this leader manages internal workflows and optimizes organizational processes to support the company's mission of providing comprehensive addiction treatment. By bridging the gap between high-level strategy and daily operations, Weidmann ensures that all departments remain focused on the core objective of improving lives. This role involves managing complex projects that span multiple regions, requiring a deep understanding of the company's evidence-based approach. Through proactive problem-solving and organizational oversight, Colin Weidmann maintains the operational rhythm necessary for the company to thrive in a competitive healthcare environment.

Nicholas Cook, the Chief Legal Officer & General Counsel at BrightView, manages all legal, regulatory, and compliance matters to protect the organization's mission. Cook architects robust frameworks that ensure adherence to healthcare laws, safeguarding both the company and the patients served. As the Chief Legal Officer & General Counsel, this leader provides critical guidance on risk management, contract negotiations, and corporate governance. By navigating the complex regulatory landscape of addiction treatment, Cook enables the organization to expand its services while maintaining strict compliance with industry standards. This role involves collaborating with the executive team to address legal challenges that arise during rapid growth. Through proactive legal strategy, Nicholas Cook ensures that the company's commitment to evidence-based care remains supported by a secure and ethical foundation. This leadership role is essential for maintaining the trust of patients and stakeholders alike.